Jim Simons Forma Therapeutics Holdings, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $2.09 Million - $5.94 Million	-293,632 Reduced 29.55%	700,100 $14 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $10.0 $1.8 Million - $3.54 Million	353,532 Added 55.22%	993,732 $6.85 Million
Q1 2022 May 13, 2022	BUY	$8.34 - $14.69 $2.52 Million - $4.44 Million	302,300 Added 89.46%	640,200 $5.95 Million
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $3.48 Million - $6.37 Million	256,000 Added 312.58%	337,900 $4.81 Million
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $1.74 Million - $2.1 Million	81,900 New	81,900 $1.9 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.